Oracle joins CancerX initiative

Oracle has joined CancerX, a digital health project that is part of the Biden administration’s “cancer moonshot” initiative aimed at reducing deaths due to cancer. 

Advertisement

As a founding member of the project, Oracle will use its background in open cloud platforms, AI and machine learning, clinical research, healthcare research, care delivery, and its recent acquisition of Cerner to provide knowledge to the project, according to a Aug. 22 press release from Oracle. 

Oracle joins other health systems and tech companies such as Amazon Web Services, Charlotte, N.C.-based Atrium Health and Oakland, Calif.-based Kaiser Permanente as founding members. 

Members of the initiative also work together to “define the value of digital innovation in cancer treatment, address methodological and implementation gaps, and develop best practices for the equitable adoption of digital health technologies for oncology,” according to the release.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Disruptors

Advertisement

Comments are closed.